Instrument Inactif

Communiqués Cepheid

Actions

US15670R1077

Equipement et technologie médicale avancés

Communiqués

15/02/17	Cepheid : Announces FDA Clearance Of Xpert® Xpress Flu And Xpert Xpress Flu/RSV	PU
05/11/16	Cepheid : Danaher Completes Acquisition Of Cepheid	PR
27/10/16	Cepheid : 30 Minute Or Less Molecular Flu/RSV Test Now Available Outside The US	PR
24/10/16	Cepheid : Announces Receipt of Required Regulatory Clearances in Proposed Acquisition by Danaher Corporation	PR
05/10/16	Cepheid : New Bladder Cancer Test Could Reduce Number Of Invasive Procedures Required For Recurrence Monitoring	PR
15/09/16	Cepheid : Announces Expansion Of The Most Comprehensive Molecular C. Difficile Product Portfolio On The Market	PR
12/09/16	Brower Piven Commences An Investigation Into The Proposed Sale Of Cepheid And Encourages Shareholders To Contact The Firm For Additional Information	BU
09/09/16	CEPHEID SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces the Investigation of Cepheid (CPHD) Over the Proposed Sale of the Company to Danaher Corporation	PR
09/09/16	Cepheid : Acquisition May Not Be in the Best Interests of CPHD Shareholders	PR
09/09/16	SHAREHOLDER UPDATE: Brodsky & Smith, LLC Announces an Investigation of The Board of Directors of Cepheid -CPHD	PR
08/09/16	Cepheid : Targets Development of a Point of Care HIV Viral Load Test From a Few Drops of Blood	PR
07/09/16	Harwood Feffer LLP : Announces Investigation of Cepheid	PR
07/09/16	Brower Piven Commences An Investigation Into The Proposed Sale Of Cepheid And Encourages Investors To Contact The Firm For Additional Information	BU
06/09/16	Cepheid :'s Xpert TV Now Cleared For Testing Symptomatic And Asymptomatic Men	PR
06/09/16	CEPHEID Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Sale to Danaher Corporation	BU
06/09/16	CEPHEID Rigrodsky & Long, P.A. Announces Investigation Of Buyout	BU
06/09/16	Cepheid : Danaher To Acquire Cepheid For $53.00 Per Share, Or Approximately $4 Billion	PR
04/08/16	Cepheid : to Webcast Upcoming Financial Presentations	PR
28/07/16	Cepheid : Reports Second Quarter 2016 Results	PR
20/07/16	Cepheid : Technical Notes on Scientific & Technical Instruments' Stocks -- Trimble Navigation, Garmin, Keysight Technologies, and Cepheid	PR
12/07/16	Cepheid : Announces Results Of Validation Study For Use Of Xpert HPV In Primary Cervical Cancer Screening	PR
07/07/16	Cepheid : Schedules 2016 Second Quarter Results Announcement And Webcast	PR
05/07/16	Cepheid : Opening Of Hammersmith Clinic Furthers The Revolution In Sexual Health Diagnostic Services	PU
30/06/16	Cepheid : FDA Supports Expanded Claims for Xpert Carba-R Test for "Superbugs"	PU
15/06/16	Cepheid : Announces World Health Organization Prequalification Of Xpert HIV-1 Qualitative Test	PR